Gemcitabine, Bendamustine, and Nivolumab in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Clinical trial NCT03739619 · COMPLETED
Trial details
- NCT number
- NCT03739619
- Sponsor
- Emory University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2023-12-22
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.